How to approach a child with growth concern

Similar documents
PedsCases Podcast Scripts

Request for Prior Authorization Growth Hormone (Norditropin

4/23/2015. Pediatric Growth Hormone Deficiency: Identification, Diagnosis, & Management. Conflict of Interest. Objectives THANK YOU!

2. Has this plan authorized this medication in the past for this member (i.e., previous authorization is on file under this plan)?

Humatrope*, Norditropin*, Genotropin, Nutropin, Nutropin AQ, Omnitrope, Saizen, Zomacton (aka. Tev-Tropin)

2. Is the request for Humatrope? Y N [If no, skip to question 6.]

Growth Hormone plus Childhood Low- Dose Estrogen in Turner s Syndrome. N Engl J Med 2011;364: Present by R5 郭恬妮

Growth hormone therapy for short stature in adolescents the experience in the University Medical Unit, National Hospital of Sri Lanka

TEXAS MEDICAID Clinical Edit Prior Authorization Growth Hormones: GENOTROPIN & NORDITROPIN Texas Children s Health Plan Only

Prior Authorization Criteria Form This form applies to Paramount Commercial Members Only. Non-Preferred Growth Hormone Products

TEXAS MEDICAID Clinical Edit Prior Authorization Growth Hormones: HUMATROPE, NUTROPIN AQ, OMNITROPE, SAIZEN

General Approval Criteria for ALL Growth Hormone agents: (ALL criteria must be met)

Original Effective Date: 7/5/2007

Why is my body not changing? Conflicts of interest. Overview 11/9/2015. None

Linear Growth Assessment: Evaluation and Causes and Treatment of Growth Failure

AETNA BETTER HEALTH Non-Formulary Prior Authorization guideline for Growth Hormone and related agents

Growth hormone therapy in a girl with Turner syndrome showing a large increase over the initially predicted ht of 4 5

Growth Hormones DRUG.00009

GROWTH HORMONE THERAPY

This CNE activity is supported by an educational grant from Novo Nordisk Inc.

Growth and DMD Endocrine aspects of care

Obesity in Children. JC Opperman

The University of Arizona Pediatric Residency Program. Primary Goals for Rotation. Endocrinology

Instructor s Manual Chapter 28 Endocrine Alterations. 1. Which of the following is an example of a negative feedback system?

Elements for a Public Summary

GROWTH HORMONE THERAPY

GROWTH HORMONE THERAPY

Growth Hormone Therapy

Endocrine: Precocious Puberty Health care guidelines for Spina Bifida

First Name. Specialty: Fax. First Name DOB: Duration:

On the go. with Norditropin. Patient travel tips

Growth and Puberty: A clinical approach. Dr Esko Wiltshire

Renee Kinman, MD PhD

CIGNA HealthCare Prior Authorization Form - Growth Hormone Medications -

Provide preventive counseling to parents and patients with specific endocrine conditions about:

Aetna Better Health of Virginia

The science behind igro

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES

Children s Hospital & Research Center Oakland. Endocrinology

PHARMACY POLICY STATEMENT Indiana Medicaid

Circle Yes or No Y N. [If yes, skip to question 30.] 2. Is this request for a child? Y N. [If no, skip to question 20.]

Diagnosing Growth Disorders. PE Clayton School of Medical Sciences, Faculty of Biology, Medicine & Health

Growth Hormone Therapy Guidelines: Clinical and Managed Care Perspectives

Growth hormone significantly increases the adult height of children with idiopathic short stature: comparison of subgroups and benefit

Genotropin, Norditropin, Nutropin, Nutropin AQ, Humatrope, Saizen,

AETNA BETTER HEALTH Prior Authorization guideline for Growth Hormone Agents

GROWTH HORMONE DEFICIENCY AND OTHER INDICATIONS FOR GROWTH HORMONE THERAPY CHILD AND ADOLESCENT

PHARMACY POLICY STATEMENT Indiana Medicaid

NOVO NORDISK A/S. 3. Pharmacotherapeutic group Somatropin is an endocrine hormone with metabolic and growth promoting effects. 4.

PREP Pediatric Endocrinology General session. Srinath Sanda, M.D. UC San Francisco

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Clinical Policy: Somatropin (Recombinant Human Growth Hormone) Reference Number: CP.PHAR.55 Effective Date: 03/11 Last Review Date: 06/17

Hyperprolactinemia in A 15-Year-Old Girl with Primary Amenorrhea

ATHLETES & PRESCRIBING PHYSICIANS PLEASE READ

GROWTH ASSESSMENT AND GROWTH DISORDERS. IAP UG Teaching slides

GH therapy in PWS (& other endocrine problems) Dr. Shankar Kanumakala Consultant Paediatrician Brighton, UK

Pharmacy Prior Authorization Growth Hormone- Clinical Guidelines

DISCLOSURES: 8/27/18 USE OF A SHARED MEDICAL APPOINTMENT FOR PEDIATRIC OBESITY

SCRIPT: Module 3. Interpreting the WHO Growth Charts for Canada SLIDE NUMBER SLIDE SCRIPT

HUMAN GROWTH HORMONE GENOTROPIN

HIGHLIGHTS OF PRESCRIBING INFORMATION DOSAGE FORMS AND STRENGTHS

Klinefelter syndrome ( 47, XXY )

PRODUCT MONOGRAPH. Pr HUMATROPE. (somatropin for injection) Biosynthetic Human Growth Hormone of Recombinant DNA Origin

ROTATION SUMMARY ENDOCRINOLOGY

Objectives. Disclosures

PFIZER INC. PROTOCOL TITLE: Efficacy and Safety of the Authentic Recombinant Human Somatropin Genotropin in Children with Familial Short Stature

Endocrine. Joe O Neil, MD, Chair

Growth Hormone!gents. WA.PHAR.50 Growth Hormone Agents

DR. SHAHJADA SELIM. Growth Hormone Deficiency. Subdivisions of Growth Hormone Deficiency. General Discussion. Signs & Symptoms

Laura Stewart, MD, FRCPC Clinical Associate Professor Division of Pediatric Endocrinology University of British Columbia

Hypothalamic & Pituitary Hormones

Norditropin SimpleXx 5 mg/1.5 ml One ml of solution contains 3.3 mg somatropin (GROWTH HORMONE HUMAN BIOSYNTHETIC)

0.33% metacresol), with a vial adapter

The Stimulation Test. What, Why, and How. Date. Time. Place. Dr./Nurse. Phone _elhmtp_HG64712_stim_br_fa3.indd 3

Humatrope*, Norditropin*, Genotropin, Nutropin, Nutropin AQ, Omnitrope, Saizen

World Health Organization Growth Standards. BC Training Module PowerPoint Speaking Notes

Humatrope*, Norditropin*, Genotropin, Nutropin, Nutropin AQ, Omnitrope, Saizen

Pediatric Gastroenterology Referral Guidelines

Statement of Medical Necessity

Expert Committee Recommendations on the Assessment, Prevention and Treatment of Child and Adolescent Overweight and Obesity

Case Report Short Stature Homeobox-Containing Haploinsufficiency in Seven Siblings with Short Stature

Puberty and Pubertal Disorders Part 3: Delayed Puberty

Pharmacy Management Drug Policy

A Crash Course in Failure to Thrive April 5, Kelly E. Wood, MD Clinical Assistant Professor Stead Family Department of Pediatrics

Growth disorders in adolescents

Falling Off the Curve Failure to Thrive

MEDICAL POLICY I. POLICY HUMAN GROWTH HORMONE MP POLICY TITLE POLICY NUMBER

This Coverage Policy applies to Individual Health Insurance Marketplace benefit plans only.

Center for healthy weight and Nutrition. Primary Care Pocket Guide to. Pediatric Obesity Management

Norditropin Cartridges [somatropin (rdna origin) injection], for subcutaneous use Initial U.S. Approval: 1987

SHORT STATURE Growth Height Measurement

Timothy Fignar, MD FAAFP

PedsCases Podcast Scripts

Clinical Standards for GH Treatment in Childhood & Adolescence.

Humatrope*, Norditropin*, Genotropin, Nutropin, Nutropin AQ, Omnitrope, Saizen

Transcription:

How to approach a child with growth concern Alaa Al Nofal, MD Assistant Professor of Pediatrics Pediatric Endocrinology Sanford Children Specialty Clinic

Nothing to disclose Disclosure

Objectives To understand the normal patterns of growth throughout childhood When to get concerned about the child s height How to evaluate a child with short stature? Management of short stature

When do children have the fastest rate of growth? 1) First year of life 2) Second year of life 3) Third year of life 4) 4 years-puberty 5) Puberty

When do children have the fastest rate of growth? 1) First year of life 2) Second year of life 3) Third year of life 4) 4 years-puberty 5) Puberty 25 cm/year 12 cm/year 8-10 cm/year 5-7 cm/year 8 cm/year for girls 10 cm/year of boys

Growth Velocity

14 year old girl, who is new to your practice, is coming to the clinic for a regular annual checkup Patient and her family have no concerns today Family reports patient has been growing along the 10 th percentile Patient has just had menarche

What is the next step in management: 1. Karyotype 2. Check TSH 3. Bone age 4. Bone age, TSH, FT4, IGF1, IGFBP3, MRI brain and referral to endocrinology 5. Plot her height on a CDC growth chart for girls

10 year old boy is coming to the clinic for a regular annual checkup He was seen by you 2 months ago for strep throat Patient and his family have no concerns today Patient has no signs of puberty on exam

What is the next step in management: 1. Dietician consult 2. Check TSH 3. Bone age 4. Bone age, TSH, FT4, IGF1, IGFBP3, brain MRI and referral to endocrinology 5. Recheck the child s height

Accurate height or length measurements are essential Inaccurate measurement or graph plotting is one of the more common causes of apparent growth failure

Measuring length and height Length: Used for children younger than 2 years of age When measured, the length should be plotted on the WHO growth chart for length At any age, measurement of length is approximately 1 cm greater than measurement of height

Measuring length and height Height: Height measurement is recommended for children over 2 years of life if possible When measured, the height should be plotted on the CDC growth chart for height

Measuring length and height Length: Recumbent position using calibrated lengthboard Fixed headpiece and movable footpiece Infant should be wearing disposable diaper with/without undershirt

Measuring length and height Height Movable head projection Hats/hair ornaments removed Head in line with head plate Horizontal axis of vision Measurer applies gentle traction beneath the jaw to maintain position Fixed measuring device attached to a wall Head, shoulders, buttocks and heels in contact with the vertical surface Shoes off Heels together

A 9 month old infant who was born to a diabetic mother is brought to the clinic for a well child checkup He has a history of transient hypoglycemia after birth Birth weight and birth length were both on the 90 th percentile He is currently on the 50 th percentile for length and 60 th percentile for weight He is healthy otherwise

What is the next step in management: 1. Dietician consult 2. Check TSH 3. Bone age 4. Bone age, TSH, FT4, IGF1, IGFBP3, MRI brain, abdominal US and referral to endocrinology 5. None of the above

It can be normal for young infants 0-6 months of age to cross percentiles on the weight or length curve Up to two-thirds of the infants at this age group are likely to cross 2 major weight for length percentiles Mei Z et al, Pediatrics. June 2004;113(6):e617-e627. Al Nofal A et all, Nut Clin Pract. Dec 2013 ;28(6):651-8

11 year old boy is new to your practice, coming for a well child checkup Mother reports that he has not been growing well He feels fine Past medical history is unremarkable Patient is pre-pubertal

What is the next step in management: 1. Dietician consult 2. Check TSH 3. Reassurance 4. MRI brain

Growth velocity is a more sensitive index of growth than is a single measurement Current growth measurements should be compared to previous growth measurements to determine the interval growth velocity

5 year old girl is coming with concern about short stature She has no symptoms Patient is pre-pubertal

Mother is 5 8 and father is 6 3

Mid-parental height/target height Girls: Father s height + Mother s height 13 cm (5 in) 2 Boys: Father s height + Mother s height + 13 cm (5 in) 2

Mid-parental height/target height Our patient s mid-parental height: (75+68-5)/2 =69

What is the next step in management: 1. Dietician consult 2. Reassurance 3. Bone age 4. Follow up in 1 year Predicted midparental height

Assuming father s height is 5 7 and mother s height is 5 feet tall Mid-parental height: (67+60-5)/2 = 61 inches (5 1) What is the next step in management: 1. Dietician consult 2. Reassurance 3. Bone age 4. Follow up in 6 month Predicted mid-parental height

Projected height Projected height for a child is determined by extrapolating the child's growth along the current channel to the 18 to 20 year mark If the child s projected height is within 8.5 cm (3-4 inches) of the midparental height, then the child's height is within the expected range for the family If the projected height is more than 8.5 cm below the midparental height, then the child can be considered abnormally short for his or her family

14 year old boy is coming to the clinic today for concerns about short stature He used to be following the 25 th percentile on the height s growth chart until 11 years of age, but currently he is on the 5 th percentile Otherwise he is a healthy boy No signs of puberty Case presentation

What is the next step in management: 1. Dietician consult 2. Check TSH 3. Bone age 4. Bone age, TSH, FT4, IGF1, IGFBP3, MRI brain, abdominal US and referral to endocrinology 5. Insulin like growth factor 1 (IGF1) level

Teenagers with constitutional delay may appear to be crossing percentiles Bone age: Determined from a radiograph of the left hand and wrist Requires expert interpretations If the bone age is delayed or advanced, the projected height should be recalculated based on the bone age rather than the chronologic age Al Nofal A et all, Nut Clin Pract. Dec 2013 ;28(6):651-8

10 year old girl is coming to the clinic for a regular checkup Family is concerned about her growth She is a picky eater No signs of puberty

What is the next step in management: 1. Endocrine referral 2. Reassurance 3. Bone age 4. Detailed diet history, medications list and GI symptoms 5. Follow up in 1 year

10 year old girl is coming to the clinic for a regular checkup Family is concerned about her growth She eats well No signs of puberty

What is the next step in management: 1. Endocrine workup 2. Reassurance 3. GI referral 4. Detailed diet history, medications list and GI symptoms 5. Follow up in 3 months

A pediatric endocrinologist is checking his patients schedule for next week A patient is scheduled to see him for obesity No outside records available except for a growth chart

The most likely cause of this patient s obesity is: 1. Severe hypothyroidism 2. Cushing disease 3. Genetic cause of obesity (Prader Willi syndrome) 4. Exogenous obesity

A pediatric endocrinologist is checking his patients schedule for next week A patient is scheduled to see him for obesity No outside records available except for a growth chart

The most likely cause of this patient s obesity is: 1. Cushing disease 2. Genetic cause of obesity (Prader Willi syndrome) 3. Exogenous obesity 4. Normal weight gain with start of puberty

3 year old child is brought to the clinic for concerns about obesity Past medical history is significant for hypotonia and feeding difficulty during infancy, for which he required G-tube Family now hides food from the child because he never seems to be full Patient has small hands and small feet

The most likely cause of this patient s obesity is: 1. Cushing disease 2. Genetic cause of obesity (Prader Willi syndrome) 3. Exogenous obesity 4. Normal weight gain

Short stature workup Before starting workup for patients with growth concerns, the following questions need to be answered: 1. Is the child short? 2. Is the child s height velocity impaired? 3. Is the child s growth within range for the family? 4. Is the child in puberty? (Is there evidence of delayed or accelerated growth?)

Differential diagnosis for short stature Short child + Normal rate of growth + short family + normal bone age Familial short stature Short child for his family + Normal rate of growth + delayed bone age Short child for his family + subnormal rate of growth + normal bone age Short child for his family + subnormal rate of growth + delayed bone age + normal weight gain Short child for his family + subnormal rate of growth + delayed bone age + poor weight gain Constitutional delay of growth and puberty Genetic cause of short stature (e.g. Turner s, Noonan Syndrome) Endocrine cause or systemic disease cause of short stature GI cause or systemic disease cause for short stature

Short stature workup Bone age CBC, CMP, ESR, CRP Celiac screen Thyroid function IGF1, IGFBP3 Growth hormone stimulation test Brain MRI Genetic testing

FDA approved indications for growth hormone Growth hormone deficiency Growth failure due to chronic kidney disease Growth failure in children born small for gestational age Prader-Willi syndrome in children Turner s syndrome Noonan syndrome Idiopathic short stature Short stature due to homeobox containing gene deficiency

Growth hormone adverse effects In addition to being a daily injections (or 6 days a week): Headaches usually benign Idiopathic intracranial hypertension Slipped capital femoral epiphysis Worsening of existing scoliosis Insulin resistance (low clinical significance) Rare adverse effects: Pancreatitis, transient gynecomastia, increase in the growth and pigmentation of nevi without malignant degeneration, etc? Cancer risk Cost!

Take home points When evaluating a child s height, it s crucial to accurately measure and plot the child s height The following information are needed when evaluating a child with growth concern: Current height Growth velocity Mid-parental height Pubertal stage Bone age is a tool that helps estimate the projected height Not every short child can be treated with growth hormone

Thank you Questions?